Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/59108
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSirada Boonyaketgosonen_US
dc.contributor.authorVatcharin Rukachaisirikulen_US
dc.contributor.authorSouwalak Phongpaichiten_US
dc.contributor.authorKongkiat Trisuwanen_US
dc.date.accessioned2018-09-05T04:38:24Z-
dc.date.available2018-09-05T04:38:24Z-
dc.date.issued2018-01-01en_US
dc.identifier.issn18736971en_US
dc.identifier.issn0367326Xen_US
dc.identifier.other2-s2.0-85034591184en_US
dc.identifier.other10.1016/j.fitote.2017.11.011en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85034591184&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/59108-
dc.description.abstract© 2017 Elsevier B.V. Four new naphthoquinones (1–4), named rhinacanthins S (1), T (2), U (3) and V (4), together with 13 known naphthoquinones were isolated from the leaf extract of Rhinacanthus nasutus. The structures of isolated compounds were elucidated by spectroscopic methods, especially 1D and 2D NMR spectroscopy and mass spectrometry. Rhinacanthin S (1) exhibited acetylcholinesterase inhibition activity with a % inhibition value of 48.04 ± 3.25. The known rhinacanthin A (5) showed cytotoxicity against a MCF-7 cell line with an IC50value of 8.79 μM, while rhinacanthin N (15) was active against the NCI-H187 cell line with an IC50= 2.24 μM and Vero cells (IC50= 3.00 μM)en_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleNaphthoquinones from the leaves of Rhinacanthus nasutus having acetylcholinesterase inhibitory and cytotoxic activitiesen_US
dc.typeJournalen_US
article.title.sourcetitleFitoterapiaen_US
article.volume124en_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsPrince of Songkla Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.